CHAMGAP
VERIFIEDPassed the Codex final verification and publication gate. Evidence-verification cutoff: 2026-09-07. AI was used for research and drafting; the existence of all 2 cited sources was verified at the original page, followed by blind grading, adversarial audit, and build validation. Methodology v0.8.
Verdict No. 2991 · Search date 2026-09-07 · Methodology v0.8

Didgeridoo playing and breathing practice averaging 25 minutes per session on 5.9 days per week,
does it really help with Reduced daytime sleepiness and AHI in moderate obstructive sleep apnea?

30-Second Summary
C
Evidence Grade C · 50 · Safety acceptable
A promising small-trial signal, not evidence of long-term complication prevention or replacement of standard treatment
No unexpected or adverse events were reported in 25 participants over four months, but this cannot exclude rare harm. Stopping established OSA treatment was not evaluated.
What the
research shows
Grade C with 50 points. In a 25-person four-month wait-list randomized trial, Epworth Sleepiness Scale scores fell 3.0 points and AHI 6.2 events per hour more than control, but there is no independent replication and participants knew their assignment.
What the
ads claim
Claims that playing an instrument cures OSA or equals standard therapy exceed the comparison.
*

Useful facts when choosing a product

  • The evidence concerns a structured training program, not a particular instrument brand.
  • Participants had BMI below 30 and AHI 15-30/h.
  • ISRCTN registration followed study initiation.
Gap Measurement · Verdict 2991 · C 50
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Twenty-five adults with BMI below 30 and moderate OSA were randomized to structured lessons and home practice or waiting for four months. Practice averaged 25.3 minutes on 5.9 days per week and all participants completed follow-up.

02

Why this is classified as C (50)

A patient-reported primary outcome, one trial, n below 200, and an unblinded subjective endpoint give grade C with 50 points.

Counterpoint. Bed-partner disturbance improved, but PSQI did not.

Rejudgment record. Codex original-trial, ISRCTN, and effect-size cross-check — Separated the ESS main outcome from AHI and null PSQI and accounted for retrospective registration, n=25, wait-list control, and unblinding

Scoring profile behind this grade
EndpointPPatient-reported treatment goal - the symptom is the goal
ReplicationR1Single confirmatory trial
IndependenceI1Mixed funding sources
Effect sizeE+Meets the clinically important threshold
PrecisionCXNo pooled confidence interval could be confirmed

The scoring table and the verdict agree (C).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Reduced daytime sleepiness in moderate OSACThe ESS difference was -3.0 points.
Replacement for standard OSA therapy?No direct comparison with standard therapy was performed.

Cross-check — AI research and Codex final gate

AI was used for research and drafting. Blind grading, adversarial audit, and the methodology boundary rules were then reapplied before Codex performed the final evidence, grade, copy, and build checks. If a grade cannot be narrowed, both evidence positions and their reasons are published.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Randomized wait-list controlled trial25Zurich Lung Association and clinical support; the training developer was a coauthorFour-month ESS main outcome; AHI and PSQIESS -3.0 (-5.7 to -0.3); AHI -6.2/h (-12.3 to -0.1); PSQI nullPromising signal from one small trial
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-09-07).

Puhan MA, Suarez A, Lo Cascio C, Zahn A, Heitz M, Braendli O. Didgeridoo playing as alternative treatment for obstructive sleep apnoea syndrome: randomised controlled trial. BMJ. 2006;332(7536):266-270. PMID: 16377643. PMCID: PMC1360393. DOI: 10.1136/bmj.38705.470590.55.
checked
ISRCTN31571714. Didgeridoo playing as alternative treatment for obstructive sleep apnoea syndrome.
checked
Research and draft: AI used · Cross-check: blind grading and adversarial audit
Final verification and publication gate: Codex · Verification cutoff: 2026-09-07 · Corrections: none

Cite this verdict

Didgeridoo Training for Sleepiness and AHI in Moderate OSA Evidence Grade C card
[Chamgap] Didgeridoo Training for Sleepiness and AHI in Moderate OSA — Evidence Grade C·50. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/sleep/didgeridoo-training-moderate-osa-sleepiness-ahi/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.